126 related articles for article (PubMed ID: 8982043)
1. Fluorescence in situ hybridization in combination with morphology detects minimal residual disease in remission and heralds relapse in acute leukaemia.
Bernell P; Arvidsson I; Jacobsson B; Hast R
Br J Haematol; 1996 Dec; 95(4):666-72. PubMed ID: 8982043
[TBL] [Abstract][Full Text] [Related]
2. Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission.
Engel H; Goodacre A; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Andreeff M
Br J Haematol; 1997 Oct; 99(1):64-75. PubMed ID: 9359505
[TBL] [Abstract][Full Text] [Related]
3. Detection of minimal residual disease using fluorescence DNA in situ hybridization: a follow-up study in leukemia and lymphoma patients.
Nylund SJ; Ruutu T; Saarinen U; Larramendy ML; Knuutila S
Leukemia; 1994 Apr; 8(4):587-94. PubMed ID: 8152255
[TBL] [Abstract][Full Text] [Related]
4. Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells.
Engel H; Drach J; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Goodacre A; Andreeff M
Leukemia; 1999 Apr; 13(4):568-77. PubMed ID: 10214863
[TBL] [Abstract][Full Text] [Related]
5. Follow-up of minimal residual disease in pediatric acute myeloblastic leukemia using metaphase-FISH.
Vettenranta K; Autio K; Hovi L; Knuutila S; Saarinen-Pihkala UM
Leuk Lymphoma; 2002 Jun; 43(6):1261-5. PubMed ID: 12152994
[TBL] [Abstract][Full Text] [Related]
6. Metaphase fluorescence in situ hybridization (FISH) in the follow-up of 60 patients with haemopoietic malignancies.
Nylund SJ; Ruutu T; Saarinen U; Knuutila S
Br J Haematol; 1994 Dec; 88(4):778-83. PubMed ID: 7819102
[TBL] [Abstract][Full Text] [Related]
7. Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patients.
Mancini M; Cedrone M; Diverio D; Emanuel B; Stul M; Vranckx H; Brama M; De Cuia MR; Nanni M; Fazi F; Mecucci C; Alimena G; Hagemeijer A
Leukemia; 2000 Mar; 14(3):364-8. PubMed ID: 10720127
[TBL] [Abstract][Full Text] [Related]
8. Fluorescence in situ hybridization evaluation of minimal residual disease on stem-cell harvests.
Díez-Martín JL; Buño I; Llamas P; Gosálvez J; López-Fernández C; Polo N; Regidor C
Cancer Detect Prev; 2000; 24(2):169-72. PubMed ID: 10917138
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometric assessment of CD15+CD117+ cells for the detection of minimal residual disease in adult acute myeloid leukaemia.
Nakamura K; Ogata K; An E; Dan K
Br J Haematol; 2000 Mar; 108(4):710-6. PubMed ID: 10792273
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of complete disease remission in acute myeloid leukemia: a prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia.
Bacher U; Kern W; Schoch C; Schnittger S; Hiddemann W; Haferlach T
Cancer; 2006 Feb; 106(4):839-47. PubMed ID: 16419072
[TBL] [Abstract][Full Text] [Related]
11. Detection of minimal residual disease in B-lineage acute lymphoblastic leukaemia by quantitative flow cytometry.
Farahat N; Morilla A; Owusu-Ankomah K; Morilla R; Pinkerton CR; Treleaven JG; Matutes E; Powles RL; Catovsky D
Br J Haematol; 1998 Apr; 101(1):158-64. PubMed ID: 9576196
[TBL] [Abstract][Full Text] [Related]
12. Follow-up of residual disease using metaphase-FISH in patients with acute lymphoblastic leukemia in remission.
El-Rifai W; Ruutu T; Vettenranta K; Elonen E; Saarinen UM; Volin L; Knuutila S
Leukemia; 1997 May; 11(5):633-8. PubMed ID: 9180284
[TBL] [Abstract][Full Text] [Related]
13. Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia: a metaphase-FISH study.
el-Rifai W; Ruutu T; Vettenranta K; Temtamy S; Knuutila S
Br J Haematol; 1996 Feb; 92(2):365-9. PubMed ID: 8603001
[TBL] [Abstract][Full Text] [Related]
14. Detection of minimal residual disease in childhood acute lymphoblastic leukaemia using fluorescence in-situ hybridization.
White DM; Crolla JA; Ross FM
Br J Haematol; 1995 Dec; 91(4):1019-24. PubMed ID: 8547114
[TBL] [Abstract][Full Text] [Related]
15. [Dynamically monitoring minimal residual disease in acute leukemia after complete remission by multiparameter flow cytometry and its relation with prognosis].
Sun NN; Gan SL; Sun H; Zhang QT; Liu YF; Xie XS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Apr; 21(2):339-42. PubMed ID: 23628028
[TBL] [Abstract][Full Text] [Related]
16. Differences in cell lineage involvement between MDS-AML and de novo AML studied by fluorescence in situ hybridization in combination with morphology.
Bernell P; Arvidsson I; Hast R; Jacobsson B; Stenke L
Eur J Haematol; 1997 Apr; 58(4):241-5. PubMed ID: 9186534
[TBL] [Abstract][Full Text] [Related]
17. Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBFbeta/MYH11 RT-PCR: implications for a monitoring schedule and for treatment decisions.
Laczika K; Mitterbauer G; Mitterbauer M; Knöbl P; Schwarzinger I; Greinix HT; Rabitsch W; Fonatsch C; Mannhalter C; Lechner K; Jaeger U
Leuk Lymphoma; 2001; 42(5):923-31. PubMed ID: 11697647
[TBL] [Abstract][Full Text] [Related]
18. [Detection of core-binding factor in acute leukemia with interphase fluorescence in situ hybridization].
Liu XL; Du QF; Song LL; Zhang S; Li R; Lin R; Liu QF; Zhou SY
Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1038-41. PubMed ID: 14559688
[TBL] [Abstract][Full Text] [Related]
19. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukaemia by reverse transcriptase polymerase chain reaction.
Mitterbauer G; Zimmer C; Pirc-Danoewinata H; Haas OA; Hojas S; Schwarzinger I; Greinix H; Jäger U; Lechner K; Mannhalter C
Br J Haematol; 2000 Jun; 109(3):622-8. PubMed ID: 10886213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
